Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Two weeks of metformin treatment induces AMPK-dependent enhancement of insulin-stimulated glucose uptake in mouse soleus muscle

Research output: Contribution to journalJournal articleResearchpeer-review

  1. A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metabolite

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Leukemia inhibitory factor increases glucose uptake in mouse skeletal muscle

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Early development of tendinopathy in humans: Sequence of pathological changes in structure and tissue turnover signaling

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Epigenome- and Transcriptome-wide Changes in Muscle Stem Cells from Low Birth Weight Men

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Skeletal muscle insulin resistance in Inuit carriers of the common Greenlandic p.Arg684Ter TBC1D4 variant is improved by a single bout of exercise

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  4. Molecular indicators of denervation in aging human skeletal muscle

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Metformin-induced activation of the 5'-AMP-activated protein kinase (AMPK) has been associated with enhanced glucose uptake in skeletal muscle, but so far no direct causality has been examined. We hypothesized that an effect of in vivo metformin treatment on glucose uptake in mouse skeletal muscles is dependent on AMPK signaling. Oral doses of metformin or saline treatment were given to muscle-specific kinase dead (KD) AMPKα2 mice and wild-type (WT) littermates either once or chronically for 2 wk. Soleus and extensor digitorum longus muscles were used for measurements of glucose transport and Western blot analyses. Chronic treatment with metformin enhanced insulin-stimulated glucose uptake in soleus muscles of WT (∼45%, P < 0.01) but not of AMPK KD mice. Insulin signaling at the level of Akt protein expression or Thr(308) and Ser(473) phosphorylation was not changed by metformin treatment. Insulin signaling at the level of Akt and TBC1D4 protein expression as well as Akt Thr(308)/Ser(473) and TBC1D4 Thr(642)/Ser(711) phosphorylation were not changed by metformin treatment. Also, protein expressions of Rab4, GLUT4, and hexokinase II were unaltered after treatment. The acute metformin treatment did not affect glucose uptake in muscle of either of the genotypes. In conclusion, we provide novel evidence for a role of AMPK in potentiating the effect of insulin on glucose uptake in soleus muscle in response to chronic metformin treatment.

Original languageEnglish
JournalA J P: Endocrinology and Metabolism (Online)
Volume306
Issue number10
Pages (from-to)E1099-109
ISSN1522-1555
DOIs
Publication statusPublished - 15 May 2014

    Research areas

  • AMP-Activated Protein Kinases, Animals, Biological Transport, Female, Glucose, Glucose Transporter Type 4, Insulin, Metformin, Mice, Mice, Inbred C57BL, Mice, Transgenic, Muscle, Skeletal, Time Factors

ID: 44835006